1. Jiffry J, Thavornwatanayong T, Rao D, Fogel EJ, Saytoo D, Nahata R, Guzik H, Chaudhary I, Augustine T, Goel S, Maitra R. Oncolytic reovirus (pelareorep) induces autophagy in KRAS-mutated colorectal cancer. Clin Cancer Res. 2020 Nov 9:clincanres.2385.2020. doi: 10.1158/1078-0432.CCR-20-2385.
2. Parakrama R, Fogel E, Chandy C, Augustine T, Coffey M, Tesfa L, Goel S, Maitra R. Immune characterization of metastatic colorectal cancer patients post reovirus administration. BMC Cancer. 2020 Jun 18;20(1):569. doi: 10.1186/s12885-020-07038-2. PMID: 32552875; PMCID: PMC7301987.
3. Rao D, Parakrama R, Augustine T, Liu Q, Goel S, Maitra R. Immunotherapeutic advances in gastrointestinal malignancies. NPJ Precis Oncol. 2019;3:4. Published 2019 Feb 5. doi:10.1038/s41698-018-0076-8.
4. Maitra R, Thavornwatanayong T, Venkatesh MK, Chandy C, Vachss D, Augustine T, Guzik H, Koba W, Liu Q, Goel S. Development and Characterization of a Genetic Mouse Model of KRAS Mutated Colorectal Cancer. Int J Mol Sci. 2019;20(22):5677. Published 2019 Nov 13. doi:10.3390/ijms20225677.
5. Augustine T, Maitra R, Zhang J, Nayak J, Goel S. Sensitization of colorectal cancer to irinotecan therapy by PARP inhibitor rucaparib. Invest New Drugs. 2019;37(5):948–960. doi:10.1007/s10637-018-00717-9.
6. Rao D, Mallick AB, Augustine T, Daroqui C, Jiffry J, Merla A, Chaudhary I, Seetharam R, Sood A, Gajavelli S, Aparo S, Rajdev L, Kaubisch A, Chuy J, Negassa A, Mariadason JM, Maitra R, Goel S. Excision repair cross-complementing group-1 (ERCC1) induction kinetics and polymorphism are markers of inferior outcome in patients with colorectal cancer treated with oxaliplatin. Oncotarget. 2019;10(53):5510–5522. Published 2019 Sep 17. doi:10.18632/oncotarget.27140
7. Augustine T, Maitra R, Goel S. Telomere length regulation through epidermal growth factor receptor signaling in cancer. Genes and Cancer. 2017 May;8(5-6):550-558. PubMed PMID: 28740573.
8. Maitra R, Augustine T, Dayan Y, Chandy C, Coffey M, Goel S. Toll like receptor 3 as an immunotherapeutic target for KRAS mutated colorectal cancer. Oncotarget. 2017 May;8(21):35138-35153. PubMed PMID: 28422714.
9. Maitra R, Augustine TA, Venkatesh MK, Goel S. Reovirus Oncolysis- Role of cyclin-dependent kinase inhibitor 1. Cancer Cell & Microenvironment. 2015; 2: e750. DOI: 10.14800/ccm.750.
10. Augustine TA, Baig M, Sood A, Budagov T, Atzmon G, Mariadason JM, Aparo S, Maitra R, Goel S. Telomere length is a novel predictive biomarker of sensitivity to anti-EGFR therapy in metastatic colorectal cancer. Br J Cancer. 2015 Jan;112(2):313-8. PubMed PMID: 25412235
11. Maitra R, Seetharam R, Tesfa L, Augustine TA, Klampfer L, Coffey MC, Mariadason JM, Goel S. Oncolytic reovirus preferentially induces apoptosis in KRAS mutant colorectal cancer cells, and synergizes with irinotecan. Oncotarget. 2014 May;5(9):2807-19. PubMed PMID: 24798549; PubMed PMCID: PMC4058046.
12. Maitra R, Nayak JB, Merla A, Sood A, Augustine TA, Baig M, Reynolds DM, Mariadason JM, Aparo S, and Goel S. A Single Nucleotide Polymorphism in the MGMT gene is a novel prognostic biomarker in patients with metastatic colorectal cancer. British Journal of medicine and medical Research. DOI:10.9734/BJMMR/2014/12841.
13. Naveenkumar C, Asokkumar S, Raghunandhakumar S, Jagan S, Anandakumar P, Augustine TA, Kamaraj S, Devaki T. Potent antitumor and antineoplastic efficacy of baicalein on benzo(a)pyrene-induced experimental pulmonary tumorigenesis. Fundam Clin Pharmacol. 2012 Apr;26(2):259-70. PubMed PMID: 21323996.
14. Ramakrishnan G, Lo Muzio L, Elinos-Báez CM, Jagan S, Augustine TA, Kamaraj S, Anandakumar P, Devaki T. Silymarin inhibited proliferation and induced apoptosis in hepatic cancer cells. Cell Prolif. 2009 Apr;42(2):229-40. PubMed PMID: 19317806.
15. Anandakumar P, Jagan S, Kamaraj S, Ramakrishnan G, Titto AA, Devaki T. Beneficial influence of capsaicin on lipid peroxidation, membrane-bound enzymes and glycoprotein profile during experimental lung carcinogenesis. J Pharm Pharmacol. 2008 Jun; 60(6):803-8. PubMed PMID:18498718.
16. Ramakrishnan G, Elinos-Báez CM, Jagan S, Augustine TA, Kamaraj S, Anandakumar P, Devaki T. Silymarin downregulates COX-2 expression and attenuates hyperlipidemia during NDEA-induced rat hepatocellular carcinoma. Mol Cell Biochem. 2008 Jun;313(1-2):53-61. PubMed PMID: 18373278.
17. Ramakrishnan G, Augustine TA, Jagan S, Vinodhkumar R, Devaki T. Effect of silymarin on N-nitrosodiethylamine induced hepatocarcinogenesis in rats. Exp Oncol. 2007 Mar;29(1):39-44. PubMed PMID: 17431387.
18. Augustine TA, Sakthivel R, Ramakrishnan G, Devaki T. Squalene’s elicitation of cytoprotection against N-nitrosodiethylamine induced hepatocellular carcinoma is mediated through antioxidant mechanism. BMC Cancer (under communication).